JUVELOOK vs Rejuran vs Exosome: An Honest Skin-Booster Comparison

This is an English adaptation of a clinical article Dr. SangYoul Yun — board-certified dermatologist and Medical Director of Delight Dermatology in Gangnam, Seoul — originally published in Korean. Read the Korean original on Naver. It has been restructured and translated for international readers; all references are the author's own.

"JUVELOOK is supposed to be good, but Rejuran is said to be different, and now there's exosome too… what's the difference?" This is one of the most common questions I get in clinic. In the advertising they all look alike, but they are completely different procedures — in ingredient, mechanism, and duration. They share the same category (skin boosters), yet inside they do entirely different jobs. So that you can choose by the real difference rather than the marketing, here is how the three compare, with the clinical evidence.

1. The biggest difference — three completely different mechanisms

The three boosters differ fundamentally in "with what, and how" they act on the skin.

• JUVELOOK — the "collagen-stimulating" booster: a hybrid of PDLLA (poly-D,L-lactic acid) and non-crosslinked hyaluronic acid (HA).¹ HA provides instant hydration and volume, while PDLLA microparticles degrade gradually in the dermis, stimulating fibroblasts to induce new collagen.^1,2 In short, a booster that "stimulates your skin to make its own collagen."
• Rejuran — the "cell-repairing" booster: its main ingredient is polynucleotide (PN) extracted from salmon DNA.³ Rather than filling or stimulating collagen, PN helps repair damaged-cell DNA and normalizes fibroblast, microvascular, and skin-barrier function.^3,4 In short, a booster that "heals damaged skin."
• Exosome — the "cell-signaling" booster: nano-sized extracellular vesicles secreted by stem cells.⁵ They carry signaling molecules — growth factors, miRNA, proteins — that tell surrounding skin cells to "make collagen," "reduce inflammation," "form vessels."^5,6 In short, a booster that "activates cell-to-cell communication."

2. What the clinical studies show

JUVELOOK (PDLLA + HA)

PDLLA microparticles degrade gradually over 18–24 months, inducing collagen production.² In Seo and colleagues' study, PDLLA plus non-crosslinked HA showed significant improvement in skin elasticity, firmness, and hydration, with a reduction in fine lines.² In patients over 45 in particular, the effect lasts longer than other boosters — averaging 14–20 months. The downside is that improper injection can form nodules (lumps) in 5–8% of cases.

Rejuran (PN/PDRN)

Rejuran's PN activates the adenosine A2A receptor, increasing type I collagen synthesis and VEGF and producing an anti-inflammatory effect.⁴ It works quickly — visible improvement within 2–4 weeks — and lasts about 4–6 months.³ In Lee and colleagues' 2022 split-face, randomized, double-blind study, PN was significantly superior to HA filler for skin elasticity and texture.⁷ Satisfaction is especially high in sensitive, flush-prone, and younger skin (under 35).

Exosome

Exosomes activate the PI3K/Akt and Notch pathways, reportedly increasing collagen synthesis, modulating inflammation, and promoting angiogenesis.⁶ In Kwon and colleagues' 2020 study, human adipose-tissue stem-cell-derived exosomes combined with fractional CO2 laser showed a significant effect on acne scars.⁸ That said, exosome is a relatively new field with large regulatory differences between countries and wide quality variation between products, so it is essential to confirm the product is verified before treatment.

3. At a glance

JUVELOOK vs Rejuran vs exosome — key comparison

Feature	JUVELOOK	Rejuran	Exosome
Main ingredient	PDLLA + non-crosslinked HA	Salmon-DNA polynucleotide (PN)	Stem-cell-derived extracellular vesicles
Mechanism	Collagen stimulation	Cell repair	Cell signaling
Onset	Gradual (weeks–months)	Fast (2–4 weeks)	Faster recovery when combined
Duration	Avg 14–20 months (45+)	Avg 4–6 months	Relatively new field
Best candidate	40s+, long-term, structural firming	Early–mid 30s, sensitive/flush-prone	Recovery after laser/MTS, chronic inflammation
Specific caution	5–8% nodule risk	Disclose salmon allergy in advance	Product-quality variance, regulatory differences

4. So who does each one suit?

• JUVELOOK suits: those over 40 whose aging changes have begun in earnest, those wanting to improve pores, fine lines, and firmness together, those wanting a long-term (1+ year) effect, and those with depressed acne scars or dark circles.
• Rejuran suits: those in their early–mid 30s starting early aging care, sensitive/flush-prone/reactive skin, those wanting a fast (2–4 week) effect, and those focused on texture and tone.
• Exosome suits: those needing fast recovery after a procedure (combined with laser/MTS), those with chronic inflammation or acne marks, and those wanting to try a cutting-edge procedure (with verified products only).

5. The more important point — combining works better

Here is the real key. The three procedures work in completely different ways and are therefore complementary. JUVELOOK (collagen stimulation) firms the dermal structure itself; Rejuran (cell repair) restores damaged cells and improves texture and pores; exosome (cell signaling) activates overall regeneration signals and speeds recovery. So we often use combination protocols by patient status:

• Early 30s + overall and texture improvement: Rejuran alone, or Rejuran + JUVELOOK
• Late 30s + firmness starting to decline: Rejuran, then JUVELOOK in sequence
• 40s + established aging: JUVELOOK + exosome combined
• Immediate post-procedure recovery: exosome (soothing and regeneration after HIFU/laser)

6. Side effects and precautions

All three are relatively safe, but there are points to know. Common to all: bruising, swelling, and redness at the injection site (resolving within 3–7 days) and a temporary lumpy sensation.

• JUVELOOK: nodules can form in 5–8% — a uniform injection technique is key, and following the post-procedure massage guide is essential.
• Rejuran: a temporary lumpy sensation right after (improves with massage after 24 hours); patients with a salmon allergy must disclose it in advance.
• Exosome: because product quality varies widely, use only verified-manufacturer products, and because regulation differs by country, confirm MFDS registration.

With skin boosters, what most decides the result is "which product, by whom, and how" it is performed.

7. How we approach skin boosters at Delight Dermatology

We select the procedure that fits you — not the "trending product" — by age and skin status, and use only verified products with MFDS approval and clinical data. We judge single vs combined (is one enough, or is synergy needed) and set realistic expectations by explaining each procedure's onset and duration precisely.

Bottom line: the key is not "which is best" but "what my skin needs." Collagen structure → JUVELOOK; cell repair → Rejuran; signal activation → exosome. The three are not competitors but tools with different roles. Don't be swayed by product names — choose the procedure that fits you after an accurate diagnosis.

References

1. VAIM Global Inc. Juvelook: PDLLA + Non-crosslinked HA Hybrid Biostimulator — Product Information. 2023.
2. Seo JS, Hong WK, et al. A Prospective, Split-face, Randomized Study of the Poly-D, L Lactic Acid (PDLLA) for Photoaged Skin. ClinicalTrials.gov NCT05913102. 2023.
3. Park KY, Seok J, Rho NK, Kim BJ, Kim MN. Long-chain polynucleotide filler for skin rejuvenation: efficacy and complications in five patients. Dermatol Ther. 2016;29(1):37-40.
4. Squadrito F, Bitto A, Irrera N, et al. Pharmacological activity and clinical use of PDRN. Front Pharmacol. 2017;8:224.
5. Wang Y, Shen X, Song S, et al. Mesenchymal stem cell-derived exosomes and skin photoaging: From basic research to practical application. Photodermatol Photoimmunol Photomed. 2023;39(4):285-297.
6. Nahm WJ, et al. Exosomes in Dermatology: A Comprehensive Review of Current Applications, Clinical Evidence, and Future Directions. Int J Dermatol. 2025.
7. Lee YJ, Kim HT, et al. Comparison of the effects of polynucleotide and hyaluronic acid fillers on periocular rejuvenation: a randomized, double-blind, split-face trial. J Dermatolog Treat. 2022;33(1):254-260.
8. Kwon HH, Yang SH, Lee J, et al. Combination Treatment With Human Adipose Tissue Stem Cell-Derived Exosomes and Fractional CO2 Laser for Acne Scars: A 12-Week Prospective, Double-Blind, Randomized, Split-Face Study. Acta Derm Venereol. 2020;100:adv00310.

Medical disclaimer. This article is general information and does not replace individual consultation. A procedure's suitability, product selection, and possible side effects should be decided after an in-person consultation with a dermatologist. Exosome regulation differs by country, so confirm MFDS approval, and if you have a salmon allergy, always disclose it before a Rejuran procedure.